Simplex Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-418,700
Closed -$22K 10743
2022
Q4
$22K Buy
418,700
+95,500
+30% +$62.8K ﹤0.01% 6812
2022
Q3
$384K Sell
323,200
-118,300
-27% -$184K ﹤0.01% 3784
2022
Q2
$794K Buy
441,500
+325,800
+282% +$481K ﹤0.01% 2879
2022
Q1
$233K Buy
115,700
+73,300
+173% +$144K ﹤0.01% 4935
2021
Q4
$114K Sell
42,400
-133,100
-76% -$492K ﹤0.01% 6047
2021
Q3
$1.02M Buy
175,500
+5,700
+3% +$27.5K ﹤0.01% 3042
2021
Q2
$984K Buy
169,800
+167,910
+8,884% +$984K ﹤0.01% 3140
2021
Q1
$1.33M Sell
1,890
-303
-14% -$2.03K ﹤0.01% 2091
2020
Q4
$1.05M Buy
2,193
+349
+19% +$1.76K ﹤0.01% 2488
2020
Q3
$1.07M Buy
1,844
+625
+51% +$3.74K ﹤0.01% 2155
2020
Q2
$822K Sell
1,219
-4,115
-77% -$31.2K ﹤0.01% 2329
2020
Q1
$3.39M Sell
5,334
-207
-4% -$1.66K 0.01% 916
2019
Q4
$5.78M Buy
5,541
+2,245
+68% +$16.3K 0.01% 705
2019
Q3
$1.29M Buy
3,296
+2,157
+189% +$17.4K ﹤0.01% 1697
2019
Q2
$1.69M Buy
1,139
+812
+248% +$14.7K ﹤0.01% 1438
2019
Q1
$811K Sell
327
-141
-30% -$3.54K ﹤0.01% 2175
2018
Q4
$840K Buy
468
+7
+2% +$143 ﹤0.01% 1773
2018
Q3
$1.35M Buy
461
+370
+407% +$14.3K ﹤0.01% 1581
2018
Q2
$413K Sell
91
-308
-77% -$15K ﹤0.01% 2650
2018
Q1
$75K Sell
399
-157
-28% -$9.16K ﹤0.01% 2037
2017
Q4
$257K Buy
556
+310
+126% +$21.7K 0.01% 1099
2017
Q3
$454K Sell
246
-427
-63% -$33.9K 0.02% 720
2017
Q2
$1.42M Buy
673
+409
+155% +$25K 0.06% 261
2017
Q1
$440K Sell
264
-387
-59% -$23.5K 0.02% 747
2016
Q4
$552K Sell
651
-137
-17% -$4.82K 0.03% 500
2016
Q3
$432K Buy
788
+295
+60% +$6.33K 0.03% 587
2016
Q2
$13K Buy
493
+4
+0.8% +$58 ﹤0.01% 3365
2016
Q1
$34K Buy
489
+237
+94% +$5.02K ﹤0.01% 2319
2015
Q4
$39K Buy
252
+140
+125% +$9.03K ﹤0.01% 2123
2015
Q3
$133K Buy
112
+17
+18% +$1.47K 0.01% 1190
2015
Q2
$83K Buy
95
+59
+164% +$5.05K 0.01% 1330
2015
Q1
$51K Sell
36
-24
-40% -$1.7K 0.01% 1558
2014
Q4
$63K Buy
+60
New +$3.15K 0.01% 1214

Other funds holding CLVS